Monte Rosa Therapeutics, Inc. GLUE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.5M+3.5% | -$46.14M-70.4% | -$27.08M-120% | -$12.3M-126% | $46.89M— | ||
| $2.03M-2.8% | $2.09M-0.3% | $2.1M-1.4% | $2.13M+3.8% | $2.05M-0.6% | ||
| $5.95M+38.1% | $4.31M-1.3% | $4.36M-10.8% | $4.89M-7.6% | $5.3M+18.6% | ||
| -$37.37M+13.1% | -$43.01M-143% | $100.43M+389% | -$34.72M+23.7% | -$45.49M-135% | ||
| $1.87M+144% | $767K+17.8% | $651K-61.6% | $1.7M+6.8% | $1.59M+767% | ||
| -$261M-301% | -$65.07M— | —— | —— | -$100.23M-224% | ||
| $328.34M+1,008% | $29.62M+8,413% | $348K-4.7% | $365K+2,507% | $14K-97.7% | ||
| $29.97M+138% | -$78.46M— | —— | -$9.03M+93.8% | -$145.71M-248% | ||
| -$39.24M+10.4% | -$43.78M-144% | $99.78M+374% | -$36.42M+22.7% | -$47.08M-137% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Monte Rosa Therapeutics, Inc. generate?
- Monte Rosa Therapeutics, Inc. (GLUE) generated -$14.7M in operating cash flow over the trailing twelve months.
- What is Monte Rosa Therapeutics, Inc.'s free cash flow?
- After $5.0M of capital expenditures, Monte Rosa Therapeutics, Inc.'s free cash flow was -$19.7M over the trailing twelve months, down 164.5% year over year.
- Where does Monte Rosa Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Monte Rosa Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
